NCT05501223

Physician-initiated Medication Review in a Type 2 Diabetes Outpatient Clinic

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 50 (estimated)
• Sponsor: Bispebjerg Hospital · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

Aiming to reduce polypharmacy in patients with type 2 diabetes by using physician-initiated medication reviews.

Detailed description

Patients will be randomised to either standard care(annual visit at outpatient clinic) or standard care plus an intervention. The intervention is a medication consultation of 30-60 minutes that consist of a medication review and increased cross-sectoral communication. Follow-up is 6 months. Primary outcome are number of medications used, secondary outcomes are health related quality of life and persistance of medication changes.

Conditions

• Polypharmacy

Interventions

Type	Name	Description
OTHER	Medication review	30-60 minutes extra consultation regarding the patients drugs
OTHER	Standard care	Standard care i.e. visit at the Dept. of Endocrinology.

Timeline

• Start date: 2020-11-01
• Primary completion: 2022-11-01
• Completion: 2022-11-01
• First posted: 2022-08-15
• Last updated: 2022-08-15

Locations

1 site across 1 country: Denmark